Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLPREDNISOLONE HEMISUCCINATE for Multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where METHYLPREDNISOLONE HEMISUCCINATE was used for Multiple sclerosis.

Most Reported Side Effects for METHYLPREDNISOLONE HEMISUCCINATE

Side Effect Reports % Deaths Hosp.
Hypotension 12 7.8% 4 8
Off label use 10 6.5% 1 3
Pyrexia 10 6.5% 4 9
Hepatocellular injury 9 5.9% 0 6
Sepsis 9 5.9% 6 6
Septic shock 9 5.9% 7 7
Hypersensitivity 8 5.2% 0 6
Dyspnoea 7 4.6% 2 4
Abdominal pain 6 3.9% 2 2
Erythema 6 3.9% 0 2
Febrile bone marrow aplasia 6 3.9% 1 5
Hyperthermia 6 3.9% 3 3
Multiple organ dysfunction syndrome 6 3.9% 6 5
Oxygen saturation decreased 6 3.9% 1 4
Pneumonia 6 3.9% 1 5

Other Indications for METHYLPREDNISOLONE HEMISUCCINATE

Premedication (20) Chemotherapy side effect prophylaxis (14) Prophylaxis of nausea and vomiting (9) Chemotherapy (6) Product used for unknown indication (5) Prophylaxis against transplant rejection (5) Systemic lupus erythematosus (5)

Other Drugs Used for Multiple sclerosis

DIMETHYL (78,567) NATALIZUMAB (56,733) INTERFERON BETA-1A (56,475) FINGOLIMOD (43,123) TERIFLUNOMIDE (29,963) DALFAMPRIDINE (28,787) GLATIRAMER (27,144) OCRELIZUMAB (15,501) OFATUMUMAB (11,816) PEGINTERFERON BETA-1A (11,105)

Related Pages

METHYLPREDNISOLONE HEMISUCCINATE Full Profile All Multiple sclerosis Drugs METHYLPREDNISOLONE HEMISUCCINATE Demographics METHYLPREDNISOLONE HEMISUCCINATE Timeline